ZOGENIX, INC. License Agreements
5 Contracts & Agreements
- Amendment No. 1 to Exclusive License Agreement by and between the Trustees of Columbia University and Modis Therapeutics, Inc., dated December 5, 2019 (Filed With SEC on March 2, 2020)
- Exclusive License Agreement by and between the Trustees of Columbia University and Modis Therapeutics, Inc. (as successor-in-interest to Meves Pharmaceuticals, LLC), dated... (Filed With SEC on November 7, 2019)
- SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on May 9, 2013)
- DEVELOPMENT AND LICENSE AGREEMENT BETWEEN DURECT CORPORATION AND ZOGENIX, INC. DATED AS OF JULY 11, 2011 DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on August 12, 2011)
- FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on September 3, 2010)
